JoVE Logo

Zaloguj się

Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.

W tym Artykule

  • Podsumowanie
  • Streszczenie
  • Wprowadzenie
  • Protokół
  • Wyniki
  • Dyskusje
  • Ujawnienia
  • Podziękowania
  • Materiały
  • Odniesienia
  • Przedruki i uprawnienia

Podsumowanie

Here we present a protocol for human Dental Pulp Stem Cells isolation and propagation in order to evaluate the prion protein expression during neuronal differentiation process.

Streszczenie

Bioethical issues related to the manipulation of embryonic stem cells have hindered advances in the field of medical research. For this reason, it is very important to obtain adult stem cells from different tissues such as adipose, umbilical cord, bone marrow and blood. Among the possible sources, dental pulp is particularly interesting because it is easy to obtain in respect of bioethical considerations. Indeed, human Dental Pulp Stem Cells (hDPSCs) are a type of adult stem cells able to differentiate in neuronal-like cells and can be obtained from the third molar of healthy patients (13-19 ages). In particular, the dental pulp was removed with an excavator, cut into small slices, treated with collagenase IV and cultured in a flask. To induce the neuronal differentiation, hDPSCs were stimulated with EGF/bFGF for 2 weeks. Previously, we have demonstrated that during the differentiation process the content of cellular prion Protein (PrPC) in hDPSCs increased. The cytofluorimetric analysis showed an early expression of PrPC that increased after neuronal differentiation process. Ablation of PrPC by siRNA PrP prevented neuronal differentiation induced by EGF/bFGF. In this paper, we illustrate that as we enhanced the isolation, separation and in vitro cultivation methods of hDPSCs with several easy procedures, more efficient cell clones were obtained and large-scale expansion of the mesenchymal stem cells (MSCs) was observed. We also show how the hDPSCs, obtained with methods detailed in the protocol, are an excellent experimental model to study the neuronal differentiation process of MSCs and subsequent cellular and molecular processes.

Wprowadzenie

Mesenchymal stem cells have been isolated from several tissues, including bone marrow, umbilical cord blood, human dental pulp, adipose tissue, and blood1,2,3,4,5,6. As reported by several authors, hDPSCs show plastic adherence, a typical fibroblast-like morphology. These represent a highly heterogeneous population with distinct clones and differences in proliferative and differentiating capacity7,8. hDPSCs express specific markers for mesenchymal stem cells (i.e. CD44, CD90, CD73, CD105, STRO-1), they are negative for some hematopoietic markers (such as CD14 and CD19) and are capable of in vitro multilineage differentiation9,10,11.

Several authors have shown that these cells are able to differentiate into neuron-like cells using different protocols, that include the addition of NGF, bFGF, EGF in combination with the specific media and supplements7,12. Also, many proteins are involved during neuronal differentiation process and, among these, several papers show a relevant role and significant expression of cellular prion protein (PrPC), both in embryonic and adult stem cells13,14. PrPC represents a pleiotropic molecule capable of performing different functions inside cells as copper metabolism, apoptosis, and resistance to oxidative stress15,16,17,18,19,20,21,22.

In our previous paper23, we investigated the role of PrPC in the hDPSCs neuronal differentiation process. In fact, hDPSCs express precociously PrPC and, after neuronal differentiation, it was possible to observe an additional increase. Other authors hypothesized a possible role of PrPC in neuronal differentiation processes of stem cells. Indeed, PrPC drives the differentiation of human embryonic stem cells into neurons, oligodendrocytes, and astrocytes24. The purpose of this study was to emphasize the methodology for obtaining stem cells from dental pulp, its differentiation process and the role of PrPC during neuronal differentiation.

Access restricted. Please log in or start a trial to view this content.

Protokół

Third molars used in the study were excised from patients (13-19 years old) with no prior history of drug or alcohol consumption, all non-smoking and with appropriate oral hygiene. On the day of explanation, at the Department of Science Dentistry and Maxillofacial of "Sapienza" University of Rome, informed consent was obtained from the patients or the parents. Informed consent was obtained based on ethical considerations and approval of the ethics committee.

1. Tooth and Dental Pulp Extraction

  1. Preparation of appropriate medium for the conservation or transportation.
    1. Prepare Dulbecco's Modified Eagle's medium low concentration of glucose (DMEM-L) with L-glutamine (494.5 mL).
    2. Add 5 mL of penicillin/streptomycin (1%) and 0.5 mL of amphotericin (0.1%).
  2. Extract the third molar from the patient, quickly rinse it with PBS, put in a 15 mL test tube with the medium and transfer it to the laboratory in less than 2 h.
  3. Under a biohazard hood, open the tooth with a cutter by coronal cutting pass parallel and tangent through the roof of the pulp chamber.
  4. Gently remove the pulp with a small excavator and place it in a test tube.
  5. Wash with PBS three times and centrifuge at 2,500 x g for 10 min at RT.

2. Processing of the Dental Pulp and Stem Cell Release

  1. Remove the supernatant, resuspend the pellet in Hank's solution and place it in a Petri dish. Incubate for 2 h at 37 °C in 5% CO2.
  2. Type IV collagenase solution preparation.
    1. Prepare 0.8 mL of DMEM-L.
    2. Melt 1 mg of type IV collagenase in 0.8 mL of DMEM-L and vortex for several min.
    3. Add DMEM-L up to 1 mL to have a final concentration 1 mg/mL.
    4. Filter the solution with a 0.22 µM filter.
  3. Remove Hank's solution by centrifugation at 2,500 x g for 10 min at RT and divide the pulp into small slices approximatively 1 mm each one with a disposable scalpel.
  4. Place the pulp slices in a petri dish and incubate with 1 mL of type IV collagenase for 15 min at 37 °C in 5% CO2.
  5. Medium culture preparation (500 mL).
    1. To 445 mL of DMEM-L with L-glutamine.
    2. Add 50 mL of Fetal Bovine Serum (FBS) (10%).
    3. Add 5 mL of penicillin/streptomycin (1%).
  6. Centrifuge the sample at 2,500 x g for 10 min at RT, remove the supernatant, resuspend the pellet in the medium (step 2.5) and culture in T25 flask specific for stem cell at 37 °C in 5% CO2.

3. Stem Cell Culture and Propagation

  1. Every day check the culture and, after 3 days of growth, observe different clones of adherent cells within the flask.
  2. Every 3 days change the culture medium.
  3. Between 7 and 12 days, once the adherent cells have reach confluence, detach them by treating the cells with 1 mL of trypsin-EDTA for 3 min at 37 °C or gently using a cell scraper.
  4. Add 4 ml (ratio 1:5) of the culture medium (step 2.5) to stop trypsin action.
  5. Centrifuge the cell suspension for 6 min at 259 x g, remove the supernatant and place the cells in a T25 flask to propagate.
    NOTE: Every 3 days the cells reach confluence.
  6. Propagate the cells up to 21 or 28 days (approximately 6-8 passages) to avoid the presence of non-stem like cells in the culture.
  7. Detach the cells with 1 mL of trypsin-EDTA for 3 min at 37 °C or gently scraping. Centrifuge the cell suspension for 6 min at 259 x g.
  8. Remove the supernatant and test the cells for cytofluorimetric analysis (step 6).

4. Transient PrPC Silencing by siRNA

  1. Culture the hDPSCsin 6-well plates (2 x 105 cell/mL) with 2 mL of culture medium (step 2.5) for 24 h.
  2. The day after, prepare siRNA PrP medium (400 µL).
    1. To a sterile test tube, add 384 µL DMEM-L.
    2. Add 1 µL for each type of siRNA PrP to DMEM-L to have a final concentration of 5 nM (4 siRNA PrP were used and verified by the supplier to guarantee a knockdown efficiency ≥70%).
    3. Add 12 µL of transfectionreagent to DMEM-L.
    4. Vortex the mixture and incubate for 10 min at RT to allow the formation of transfection complexes.
  3. Add 400 μL of siRNA PrP medium to each sample and incubate for 6 h at 37 °C.
  4. Without discarding siRNA PrP medium, add 1.6 mL (ratio of 1 to 5) of culture medium (step 2.5).
  5. Leave the cells for 72 h at 37 °C.
  6. Remove the supernatant and wash 3 times with 2 mL of PBS at RT.
  7. Add 2 mL of neuronal culture medium for 7 and/or 14 days (step 5.1).
  8. Change the neuronal culture medium every 3 days.
    NOTE: Replace the siRNA PrP solution each time replace the neuronal culture medium.
  9. At end of the time, wash 3 times with 2 mL of PBS at RT and test for neuronal surface antigens by Western Blot analysis.

5. Neuronal Induction Process of hDPSCs

  1. Neuronal culture medium preparation (500 mL).
    1. Prepare 444.7 mL of basal media formulated to neuronal cells.
    2. To the medium add 50 mL of serum-free supplement used for supporting the long-term viability of embryonic and adult neuronal stem cells (10%).
    3. Add 200 µL of basic Fibroblast Growth Factor (bFGF) (final concentration 40 ng/mL) and 100 µL of Epidermal Growth Factor (EGF) to the medium (final concentration 20 ng/mL).
    4. Add 5 mL of penicillin/streptomycin (1%) to the medium.
  2. Culture hDPSCs in 6-well plates (2 x 105 cell/mL) up to 28 days from the pulp separation and stimulate them with 2 mL of neuronal culture medium.
  3. Every 3 days discard the supernatant, wash 3 times with 2 mL of PBS at RT and replace 2 mL of the neuronal culture medium.
  4. After 7 and/or 14 days, detach the cells with 1 mL of trypsin-EDTA for 3 min at 37 °C or gently with a scraper.
  5. Add 4 mL (ratio 1:5) of culture medium (step 2.5) to stop trypsin action.
  6. Test for the presence of neuronal surface antigens (step 6) or prion protein expression (step 7) by flow cytometry analysis.

6. Characterization of hDPSCs by Flow Cytometry

  1. Select mesenchymal stromal (MSC)-specific or neuronal surface antigens.
  2. Culture the hDPSCs in 6-well plates (2 x 105 cell/mL) with 2 mL of culture medium (step 2.5).
  3. Detach hDPSCs at 28 days from dental pulp separation or after 14 days of neuronal culture medium (step 5.1) with 1 mL of trypsin-EDTA for 3 min at 37 °C or gently scraper.
  4. add 4 ml (ratio 1:5) of culture medium (step 2.5) to stop trypsin action and centrifugate at 259 x g for 6 min at RT. Wash another 2 times with 2 mL of PBS at RT.
  5. Fix the untreated or treated hDPSCs with 4% paraformaldehyde in PBS for 10 min at 4 °C.
  6. Permeabilize hDPSCS with 0.1% (v/v) non-ionic surfactant in PBS for additional 10 min at RT.
  7. Perform the blocking with 5% nonfat dried milk in 1 mL of PBS for 1 h at RT.
  8. Wash 3 times with 1 mL of PBS and incubate the cells with anti-CD105 (1:100/5 x 105 cells), anti-CD44 (1:100/5 x 105 cells), anti-STRO-1 (1:100/5 x 105 cells), anti-CD90 (1:100/5 x 105 cells), anti-CD73 (1:100/5 x 105 cells), anti β3-Tubulin (1:100/5 x 105 cells), anti-NFH (1:100/5 x 105 cells) and anti-GAP43 (1:100/5 x 105 cells) mAb for 1 h at RT.
  9. Wash the cells 3 times with 1 mL of PBS and incubate with anti-mouse PE (1:50/5 x 105 cells) or anti-rabbit CY5 (1:50/5 x 105 cells) mAb for additional 1 h at RT.
  10. Use the secondary antibodies for gating the immunopositive cells (anti-mouse PE or anti-rabbit CY5 mAb) and analyze all samples with a Flow cytometer and acquire at least 20,000 events.

7. Evaluation of PrPC Expression in hDPSCs by Flow Cytometry Analysis

  1. Culture the hDPSCsin 6-well plates (2 x 105 cell/mL) with 2 mL of culture medium (step 2.5).
  2. Detach hDPSCs at 21 and 28 days from dental pulp separation and after 7 and/or 14 days with neuronal culture medium (step 5.1) with 1 mL of trypsin-EDTA and stop the trypsin action as described in step 6.4. Fix the specimens with 4% paraformaldehyde in PBS for 10 min at 4 °C.
  3. Permeabilize with 0.1% (v/v) non-ionic surfactantin PBS for 10 min at RT. Remove the supernatant and stain the cells with rabbit anti-PrP mAb EP1802Y (1:50/5 x 105 cells) mAb for 1 h at RT. Incubate with anti-rabbit CY5 (1:50/5 x 105 cells) mAb for additional 1 h at RT.
  4. Analyze all samples with a Flow cytometer and acquire at least 20,000 events.

Access restricted. Please log in or start a trial to view this content.

Wyniki

The isolation and separation procedures of hDPSCs from dental pulp, obtained from the third molar, are complex processes in which small changes can lead a ruinous result. In this paper, we use the protocol of Arthur et al.12 with several improvements. A representative scheme of procedures is shown in Figure 1.

hDPSCs represents a heterogeneous population of cells wit...

Access restricted. Please log in or start a trial to view this content.

Dyskusje

In this work, we focused on methodology for isolation and neuronal differentiation of hDPSCs; moreover, we evaluated the role of PrPC in this process. There are several methods to isolate and differentiate hDPSCs in neuron-like cells and critical steps during the process. hDPSCs are able to differentiate in several lineages such as chondroblasts, adipocytes, osteoblasts, and neurons. In our paper, we investigated the mechanisms of neuronal differentiation and the presence of PrPC. As discussed above...

Access restricted. Please log in or start a trial to view this content.

Ujawnienia

The authors have nothing to disclose.

Podziękowania

This work was supported by "Fondazione Varrone" and Rieti University Hub "Sabina Universitas" to Vincenzo Mattei.

Figure 5 (A, B) reprinted by permission of the publisher Taylor & Francis Ltd from: Role of Prion protein-EGFR multimolecular complex during neuronal differentiation of human dental pulp-derived stem cells. Martellucci, S., Manganelli V., Santacroce C., Santilli F., Piccoli L., Sorice M., Mattei V. Prion. 2018 Mar 4. Taylor & Francis Ltd.

Access restricted. Please log in or start a trial to view this content.

Materiały

NameCompanyCatalog NumberComments
Amphotericin B solutionSigma-AldrichA2942It is use to supplement cell culture media, it is a polyene antifungal antibiotic from Streptomyce
Anti-B3tubulinCell Signaling Technology #4466One of six B-tubulin isoform, it is expressed highly during fetal and postnatal development, remaining high in the peripheral nervous system
Anti-CD105 BD Biosciences611314Endoglin (CD105), a major glycoprotein of human vascular endothelium, is a type I integral membrane protein with a large extracellular region, a hydrophobic transmembrane region, and a short cytoplasmic tail
Anti-CD44MilliporeCBL154-20ulPositive cell markers antibodies directed against mesenchymal stem cells
Anti-CD73 Cell Signaling Technology 13160CD73 is a 70 kDa glycosyl phosphatidylinositol-anchored, membrane-bound glycoprotein that catalyzes the hydrolysis of extracellular nucleoside monophosphates into bioactive nucleosides
Anti-CD90MilliporeCBL415-20ulPositive cell markers antibodies directed against mesenchymal stem cells
Anti-GAP43 Cell Signaling Technology #8945Is a nervous system specific, growth-associated protein in growth cones and areas of high plasticity
Anti-mouse PE Abcamab7003Is an antibody used in in flow cytometry or FACS analysis
Anti-NFH Cell Signaling Technology #2836Is an antibody that detects endogenous levels of total Neurofilament-H protein
Anti-PrP mAb EP1802Y Abcamab52604Rabbit monoclonal [EP 1802Y] to Prion protein PrP
Anti-rabbit CY5 Abcamab6564Is an antibody used in in flow cytometry or FACS analysis
Anti-STRO 1MilliporeMAB4315-20ulPositive cell markers antibodies directed against mesenchymal stem cells
B27 Supp XF CTSGibco by life technologiesA14867-01B-27  can be used to support induction of human neural stem cells (hNSCs) from pluripotent stem cells (PSCs), expansion of hNSCs, differentiation of hNSCs, and maintenance of mature differentiated neurons in culture
BD Accuri C6 flow cytometer BD BiosciencesAC6531180187Flow cytometer equipped with a blue laser (488 nm) and a red laser (640 nm)
BD Accuri C6 Software BD BiosciencesControls the BD Accuri C6 flow cytometer system in order to acquire data, generate statistics, and analyze results
bFGFPeproThec, DBA100-18Bbasic Fibroblast Growth Factor 
Centrifuge CL30RTermo fisher Scientific11210908it is a device that is used for the separation of fluids,gas or liquid, based on density
CO2 Incubator 3541Termo fisher Scientific317527-185it ensures optimal and reproducible growth conditions for cell cultures
Collagenase, type IV Life Technologies17104019Collagenase is a protease that cleaves the bond between a neutral amino acid (X) and glycine in the sequence Pro-X-Glyc-Pro, which is found with high frequency in collagen
Disposable scalpel Swann-Morton501It is use to cut tissues
DMEM-LEurocloneECM0060LDulbecco's Modified Eagle's Medium Low Glucose with L-Glutamine with Sodium Pyruvate
EGFPeproThec, DBAAF-100-15Epidermal Growth Factor 
Fetal Bovine SerumGibco by life technologies10270-106FBS is a popular media supplement because it provides a wide array of functions in cell culture. FBS delivers nutrients, growth and attachment factors and protects cells from oxidative damage and apoptosis by mechanisms that are difficult to reproduce in serum-free media (SFM) systems
Filtropur BT50 0.2,500 mL Bottle top filterSarstedt831,823,101it is a device that is used for filtration of solutions
Flexitube GeneSolution for PRNPQiagenGS56214 siRNAs for Entrez gene 5621. Target sequence N.1 TAGAGATTTCATAGCTATTTA  N.2 CAGCAAATAACCATTGGTTAA  N.3. CTGAATCGTTTCATGTAAGAA  N.4  CAGTGACTATGAGGACCGTTA
Hank's solution 1xGibco by life technologies240200083The essential function of Hanks′ Balanced Salt solution is to maintain pH as well as osmotic balance. It also provides water and essential inorganic ions to cells
HiPerFect Transfection Reagent Qiagen301705HiPerFect Transfection Reagent is a unique blend of cationic and neutral lipids that enables effective siRNA uptake and efficient release of siRNA inside cells, resulting in high gene knockdown even when using low siRNA concentrations
Neurobasal A Gibco by life technologies10888022Neurobasal-A Medium is a basal medium designed for long-term maintenance and maturation of pure post-natal and adult brain neurons 
ParaformaldehydeSigma-Aldrich30525-89-4Paraformaldehyde has been used for fixing of cells and tissue sections during staining procedures
penicillin/streptomycin EurocloneECB3001D It is use to supplement cell culture media to control bacterial contamination
Phosphate buffered saline  (PBS)EurocloneECB4004LX10 PBS is a balanced salt solution used for the handling and culturing of mammalian cells. PBS is used to to irrigate, wash, and dilute mammalian cells. Phosphate buffering maintains the pH in the physiological range
TC-Platte 6 well, Cell+,FSarstedt833,920,300It is a growth surface for adherent cells
Tissue culture flask T-25,Cell+,Vented CapSarstedt833,910,302Tissue culture flask T-25, polystyrene, Cell+ growth surface for sensitive adherent cells, e.g. primary cells, canted neck, ventilation cap, yellow, sterile, Pyrogen-free, non-cytotoxic, 10 pcs./bag
Triton X-100 Sigma-Aldrich9002-93-1Widely used non-ionic surfactant for recovery of membrane components under mild non-denaturing conditions
Trypsin-EDTA EurocloneECB3052D Trypsin will cleave peptides on the C-terminal side of lysine and arginine amino acid residues. Trypsin is used to remove adherent cells from a culture surface
TubeSarstedt62,554,502Tube 15 mL, 120 mm x17 mm, PP
VBH 36 C2 CompactSterilST-003009000Offers totally protection for the enviroment and worker
ZEISS Axio Vert.A1 – Inverted MicroscopeZeiss3849000962ZEISS Axio Vert.A1 provides a unique entry level price and can provide all contrasting techniques, including brightfield, phase contrast, PlasDIC, VAREL, improved Hoffman Modulation Contrast (iHMC), DIC and fluorescence. Incorporate LED illumination for gentle imaging for fluorescently-labeled cells. Axio Vert.A1 is ergonomically designed for routine work and compact enough to sit inside tissue culture hoods.

Odniesienia

  1. Robey, P. G., Kuznetsov, S. A., Riminucci, M., Bianco, P. Bone marrow stromal cell assays: in vitro and in vivo. Methods in Molecular Biology. 1130, 279-293 (2014).
  2. Jiang, Y., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 418, 1-49 (2002).
  3. Kern, S., Eichler, H., Stoeve, J., Kluter, H., Bieback, K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 24, 1294-1301 (2006).
  4. Zannettino, A. C. W., et al. Multi-potential Human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. Journal of Cellular Physiology. 214, 413-421 (2008).
  5. Mattei, V., et al. Role of lipid rafts in neuronal differentiation of dental pulp-derived stem cells. Experimental Cell Research. 339, 231-240 (2015).
  6. Jansen, J., Hanks, S., Thompson, J. M., Dugan, M. J., Akard, L. P. Transplantation of hematopoietic stem cells from the peripheral blood. Journal of Cellular and Molecular Medicine. 9 (1), 37-50 (2005).
  7. Young, F. I., et al. Clonal heterogeneity in the neuronal and glial differentiation of dental pulp stem/progenitor cells. Stem Cells International. 2016, 1290561(2016).
  8. Pisciotta, A., et al. Human dental pulp stem cells (hDPSCs): isolation, enrichment and comparative differentiation of two sub-populations. BMC Developmental Biology. 15, 14(2015).
  9. Atari, M., et al. Dental pulp of the third molar: a new source of pluripotent-like stem cells. Journal of Cell Science. 125, 3343-3356 (2012).
  10. Koyama, N., Okubo, Y., Nakao, K., Bessho, K. Evaluation of pluripotency in human dental pulp cells. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons. 67, 501-506 (2009).
  11. Gronthos, S., et al. Stem cell properties of human dental pulp stem cells. Journal of Dental Research. 81, 531-535 (2002).
  12. Arthur, A., Rychkov, G., Shi, S., Koblar, S. A., Gronthos, S. Adult human dental pulp stem cells differentiate toward functionally active neurons under appropriate environmental cues. Stem Cells. 7, 1787-1795 (2008).
  13. Lee, Y. J., Baskakov, I. V. The cellular form of the prion protein is involved in controlling cell cycle dynamics, self-renewal, and the fate of human embryonic stem cell differentiation. Journal of Neurochemistry. 124, 310-322 (2013).
  14. Steele, A. D., Emsley, J. G., Ozdinler, P. H., Lindquist, S., Macklis, J. D. Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis. Proceedings of the National Academy of Sciences of the United States of America. 103, 3416-3421 (2006).
  15. Wulf, M. A., Senatore, A., Aguzzi, A. The biological function of the cellular prion protein: an update. BMC Biology. 15, 34(2017).
  16. Mattei, V., et al. Recruitment of cellular prion protein to mitochondrial raft-like microdomains contributes to apoptosis execution. Molecular Biology of the Cell. 22, 4842-4853 (2011).
  17. Linden, R. The Biological Function of the Prion Protein: A Cell Surface Scaffold of Signaling Modules. Frontiers in Molecular Neuroscience. 10, 77(2017).
  18. Garofalo, T., et al. Role of mitochondrial raft-like microdomains in the regulation of cell apoptosis. Apoptosis. , 621-634 (2015).
  19. Watt, N. T., et al. Reactive oxygen species-mediated beta-cleavage of the prion protein in the cellular response to oxidative stress. The Journal of Biological Chemistry. 280, 35914-35921 (2005).
  20. Mattei, V., et al. Morphine Withdrawal Modifies Prion Protein Expression in Rat Hippocampus. PLoS One. 12, 0169571(2017).
  21. Hu, W., et al. Prion proteins: physiological functions and role in neurological disorders. Journal of the Neurological Sciences. 264, 1-8 (2008).
  22. Sorice, M., et al. Trafficking of PrPC to mitochondrial raft-like microdomains during cell apoptosis. Prion. 6, 354-358 (2012).
  23. Martellucci, S., et al. Role of Prion protein-EGFR multimolecular complex during neuronal differentiation of human dental pulp-derived stem cells. Prion. 12 (2), 117-126 (2018).
  24. Lee, Y. J., Baskokov, I. V. The cellular form of the prion protein guides the differentiation of human embryonic stem cell into neuron-, oligodendrocyte- and astrocyte-committed lineages. Prion. 8, 266-275 (2014).
  25. Huang, G. T., Sonoyama, W., Chen, J., Park, S. H. In vitro characterization of human dental pulp cells: various isolation methods and culturing environments. Cell and Tissue Research. 324, 225-236 (2006).
  26. Suchanek, J., et al. Dental pulp stem cells and their characterization. Biomedical papers of the Medical Faculty of the University Palacký. 153, Olomouc, Czechoslovakia. 31-35 (2009).
  27. Bressan, E., et al. Donor age-related biological properties of human dental pulp stem cells change in nanostructured scaffolds. PLoS One. 7 (11), 49146(2012).

Access restricted. Please log in or start a trial to view this content.

Przedruki i uprawnienia

Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE

Zapytaj o uprawnienia

Przeglądaj więcej artyków

Stem Cell IsolationHuman Dental PulpRegenerative MedicineBiobankDental Pulp Stem CellsNeuronal DifferentiationPrion Protein ExpressionCentrifugation ProtocolCulture MediumTrypsin EDTA SolutionCell PropagationExtraction ProcedureMolar ExtractionBiohazard HoodCollagenase Treatment

This article has been published

Video Coming Soon

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone